{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ciclesonide+nasal+spray", "query": { "intervention": "ciclesonide nasal spray" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 25, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ciclesonide+nasal+spray&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-23T02:55:59.001Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01067105", "title": "A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "ciclesonide HFA 160 μg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 824, "start_date": "2010-02", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2012-06-13", "last_synced_at": "2026-09-23T02:55:59.001Z", "location_count": 44, "location_summary": "Huntington Beach, California • Los Angeles, California • Mission Viejo, California + 36 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Palmdale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01067105" }, { "nct_id": "NCT00659750", "title": "To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rhinitis, Allergic, Perennial" ], "interventions": [ { "name": "Ciclesonide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 418, "start_date": "2003-12", "completion_date": "2005-04", "has_results": false, "last_update_posted_date": "2016-12-02", "last_synced_at": "2026-09-23T02:55:59.001Z", "location_count": 23, "location_summary": "Encinitas, California • Long Beach, California • Los Angeles, California + 19 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00659750" }, { "nct_id": "NCT01550471", "title": "Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma", "Allergic Rhinitis" ], "interventions": [ { "name": "Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo", "type": "DRUG" }, { "name": "Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase", "type": "DRUG" }, { "name": "QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo", "type": "DRUG" }, { "name": "QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris", "type": "DRUG" }, { "name": "Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase", "type": "DRUG" }, { "name": "Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "West Penn Allegheny Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Years", "maximum_age": "15 Years", "sex": "ALL", "summary": "6 Years to 15 Years" }, "enrollment_count": 22, "start_date": "2012-03", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2020-11-04", "last_synced_at": "2026-09-23T02:55:59.001Z", "location_count": 2, "location_summary": "Green Tree, Pennsylvania • Pittsburgh, Pennsylvania", "locations": [ { "city": "Green Tree", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01550471" }, { "nct_id": "NCT01378429", "title": "Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis", "PAR" ], "interventions": [ { "name": "ciclesonide nasal aerosol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 89, "start_date": "2011-07", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2014-05-26", "last_synced_at": "2026-09-23T02:55:59.001Z", "location_count": 7, "location_summary": "Costa Mesa, California • Stockbridge, Georgia • Normal, Illinois + 4 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Stockbridge", "state": "Georgia" }, { "city": "Normal", "state": "Illinois" }, { "city": "Plymouth", "state": "Minnesota" }, { "city": "El Paso", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01378429" }, { "nct_id": "NCT00793858", "title": "A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Allergic Rhinitis" ], "interventions": [ { "name": "placebo, isotonic ciclesonide, hypotonic ciclesonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2009-02", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-06-07", "last_synced_at": "2026-09-23T02:55:59.001Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00793858" }, { "nct_id": "NCT01287364", "title": "Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "ciclesonide hydrofluoroalkane (HFA) nasal aerosol", "type": "DRUG" }, { "name": "mometasone nasal inhalation", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 185, "start_date": "2011-02", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-11-02", "last_synced_at": "2026-09-23T02:55:59.001Z", "location_count": 6, "location_summary": "Mission Viejo, California • San Diego, California • North Dartmouth, Massachusetts + 3 more", "locations": [ { "city": "Mission Viejo", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "Minneappolis", "state": "Minnesota" }, { "city": "Skillman", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01287364" }, { "nct_id": "NCT01401465", "title": "Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "ciclesonide", "type": "DRUG" }, { "name": "mometasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 327, "start_date": "2011-07", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2013-04-30", "last_synced_at": "2026-09-23T02:55:59.001Z", "location_count": 15, "location_summary": "Huntington Beach, California • Mission Veijo, California • San Diego, California + 11 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Mission Veijo", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01401465" }, { "nct_id": "NCT01033825", "title": "Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "Ciclesonide HFA Nasal Aerosol 320 mcg", "type": "DRUG" }, { "name": "Ciclesonide HFA Nasal Aerosol 160 mcg", "type": "DRUG" }, { "name": "HFA Nasal Aerosol placebo", "type": "DRUG" }, { "name": "Ciclesonide Aqueous Nasal Spray 200 mcg", "type": "DRUG" }, { "name": "AQ Nasal Spray Placebo", "type": "DRUG" }, { "name": "Placebo plus Dexamethasone HFA", "type": "DRUG" }, { "name": "Placebo AQ plus Dexamethasone 6 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 310, "start_date": "2010-01", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2012-07-19", "last_synced_at": "2026-09-23T02:55:59.001Z", "location_count": 6, "location_summary": "Stockbridge, Georgia • North Dartmouth, Massachusetts • Minneappolis, Minnesota + 3 more", "locations": [ { "city": "Stockbridge", "state": "Georgia" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "Minneappolis", "state": "Minnesota" }, { "city": "Skillman", "state": "New Jersey" }, { "city": "New Braunfels", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01033825" }, { "nct_id": "NCT00659048", "title": "Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rhinitis, Allergic, Perennial" ], "interventions": [ { "name": "Ciclesonide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 106, "start_date": "2004-12", "completion_date": "2005-12", "has_results": false, "last_update_posted_date": "2016-12-01", "last_synced_at": "2026-09-23T02:55:59.001Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00659048" }, { "nct_id": "NCT00305487", "title": "Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hay Fever", "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "Ciclesonide nasal spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 660, "start_date": "2006-03", "completion_date": "2006-10", "has_results": false, "last_update_posted_date": "2016-11-30", "last_synced_at": "2026-09-23T02:55:59.001Z", "location_count": 71, "location_summary": "Birmingham, Alabama • Hot Springs, Arkansas • Costa Mesa, California + 65 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00305487" } ] }